Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Brief musings...

"To me, it is looking more like a TPL merger is in the cards."

Hm...but why did Mr. Goerner accept the point in his contract, that 2mio options are getting worthless in a case of a TPL-merger? Maybe a TPL/PTSC-merger is ONE possibility (or even a consequence), IF OTHER plans by RG don't work out?

GLTY

Share
New Message
Please login to post a reply